News

FDA Approves First Twice-a-Year HIV Prevention Shot
FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...
Dailymotion on MSN43m
US FDA approves Gilead’s twice-yearly injection for HIV prevention
The US Food and Drug Administration approves Wednesday, June 18, Gilead Sciences lenacapavir, a twice-yearly injection, for ...
KFF Health News1h
FDA Green-Lights Gilead Sciences’ Groundbreaking HIV Prevention Drug
A twice-yearly injection of lenacapavir would offer near-complete protection against the virus, clinical date indicate. More pharmaceutical news is about Dupixent, GLP-1 results, and more.
Healio1h
VIDEO: Sacituzumab govitecan combo improves survival in triple-negative breast cancer
In this video, Megan Kruse, MD, breast medical oncologist at Cleveland Clinic, discusses primary results from ASCENT-04 evaluating sacituzumab govitecan plus pembrolizumab in metastatic ...
ConsumerAffairs3h
FDA approves twice-yearly injection for HIV prevention
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
Wyoming Tribune Eagle15h
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...
Queerty19h
FDA approves world’s first twice-yearly PrEP injection
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Dallas Voice20h
FDA approves first twice-a-year PrEP injectable
The U.S. Food and Drug Administration this week approved Gilead Sciences’ twice-a-year shot, lenacapvir, to prevent HIV, Gilead announced on Wednesday, June 18. It is the first and only long-acting ...
FDA approves first twice-yearly injection that prevents HIV infection
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...
IFLScience22h
Revolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA Approval
The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
Rolling Out22h
96% breakthrough transforms HIV prevention forever
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.